Compensatory activation of Akt in response to mTOR and Raf inhibitors – A rationale for dual-targeted therapy approaches in neuroendocrine tumor disease-Reference-Cited by-同舟云学术

Compensatory activation of Akt in response to mTOR and Raf inhibitors – A rationale for dual-targeted therapy approaches in neuroendocrine tumor disease

Published:2010-09 Issue:1 Volume:295 Page:100-109
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zitzmann Kathrin,Rüden Janina von,Brand Stephan,Göke Burkhard,Lichtl Jennifer,Spöttl Gerald,Auernhammer Christoph J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. The diagnosis and medical management of advanced neuroendocrine tumors;Kaltsas;Endocr. Rev.,2004

2. Natural history of neuroendocrine enteropancreatic tumors;Mignon;Digestion,2000

3. Cotargeting survival signaling pathways in cancer;Grant;J. Clin. Invest.,2008

4. Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia;Steelman;Leukemia,2008

5. MTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt;O’Reilly;Cancer Res.,2006

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model;Cell Death Discovery;2024-03-29

2. Quenching thirst with poison? Paradoxical effect of anticancer drugs;Pharmacological Research;2023-12

3. Impact of the PI3K-alpha inhibitor alpelisib on everolimus resistance and somatostatin receptor expression in an orthotopic pancreatic NEC xenograft mouse model;Endocrine-Related Cancer;2023-11-09

4. MEK/ERK and PI3K/AKT pathway inhibitors affect the transformation of myelodysplastic syndrome into acute myeloid leukemia via H3K27me3 methylases and de‑methylases;International Journal of Oncology;2023-11-03

5. Gemcitabine elaidate and ONC201 combination therapy inhibits pancreatic cancer in a KRAS mutated syngeneic mouse model;2023-07-11